IR

IRLAB Therapeutics ABSTO IRLAB Therapeutics Stock Report

Last reporting period 30 Sep, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

0.254

Micro

Exchange

XSTO - Nasdaq STOCKHOLM AB

View Full Company Analysis

IRLAB Current ratio

1.4

Last period Current ratio


What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio of IRLAB Therapeutics ?

IRLAB Therapeutics`s Current ratio for the last twelve months ended 2024-09-30 is 1.4

View Full Company Analysis